BioAxis Research Home

BioAxis Research

 

Key Activities

 

BioAxis Research offers

 

  • Collaborative research to identify leads and develop drug candidates
  • Cheminformatics, molecular property calculations, data mining
  • Structure, Fragment-based drug design, Computational Medicinal Chemistry
  • Combined data, text and network mining, association analyses

 

Expertise

 

Strong Pharma Background in industry-leading cheminformatics and compound analysis. We help clients progress early stage discovery activities, working collaboratively to implement in silico drug design techniques, maximizing the potential of compounds to reach later development stages.

Our expertise covers:

 

  • Compound collection analyses and library design
  • Structure-activity relationships
  • Multiparameter compound optimization
  • Compound progressibility analyses

 

Capabilities

 

Our success relies on secure professional collaboration, solid experience in pharmaceutical research and the most up-to-date computational tools.

 

A variety of applications are available covering Pharma and non-Pharma research. Our expertise ranges from industry leading commercially licensed molecular modelling suites, to open source workflow systems and relational databases.

 

 

Contact:

Tel +31 (0)653589156

Visiting Address RK1332| Pivot Park Oss | Molenstraat 110 | 5342 AC | Oss | The Netherlands

Postal Address RK1332| Pivot Park Oss | Molenweg 79 | 5349 AC | Oss | The Netherlands

e-mail contact@bioaxisresearch.com

 

Voorwaarden

 

Latest News

Q1 2018

 

Further publication on drug design workflows as part of 3D-e-Chem consortium work.

 

Collaboration work continues and now includes small biotechs, EU & US pharma, EU chemistry providers & EU screening centers

 

Q3-4 2017

 

The International Chemical Design Course at RadboudUMC has taken place, including lectures and hands-on KNIME practicals given by BioAxis Research and the 3D-e-Chem consortium.

 

Collaboration work continues and now includes small biotechs, EU & US pharma, EU chemistry providers & EU screening centers

 

Q2 2017

 

BioAxis Research has recieved subsidy funding for a project "Multi-Target Metabolic Syndrom Drugs" (STIMULUS funding, MKB Innovatiestimulering topsectoren Zuid-Nederland).

 

Collaboration work continues and now includes small biotechs, EU & US pharma, EU chemistry providers & EU screening centers

 

Q1 2017

 

The 3D-e-Chem consortium, a team of chem- and bioinformatics researchers [CMBI (Radboudumc), Netherlands eScience Center, BioAxis Research, and Vrije Universiteit Amsterdam] have developed an open source virtual machine for computer-aided drug design. Described in a recent publication, the computational building blocks (nodes) that enable researchers to design their own drug discovery workflows are now incorporated in KNIME, the leading open data analytics platform.

 

Q4 2016

 

COILED collaboration funded by an EFRO grant begins

 

Collaboration work continues with small biotechs/large pharma/European screening centersQ3 2016

 

Collaboration work continues with small biotechs/large pharma/European screening centers

 

3D-e-Chem VM and Knime nodes updated

 

Q1/Q2 2016

 

3d-e-Chem poster presented at Knime Spring Summit detailing progress on 3d-echem Virtual Machine and Knime nodes

 

Collaboration work continues with small biotechs. New collaboration with big pharma

 

Q3/Q4 2015

 

Chemical Analytics Platform made available: A Virtual Machine encompassing the work performed on the Chemical Analytics Platform project is now available on Github

https://github.com/NLeSC/Chemical-Analytics-Platform

 

Ongoing collaborations continue, are extended

 

Q1/Q2 2015

 

Ongoing collaborations continue, are extended

 

Q4 2014

 

Netherlands e-science center Project involves BioAxis Resarch

 

Exclusive R&D collaboration BioAxis Research and Okklo Life Science

 

Ongoing collaborations continue, are extended

 

Q3 2014

 

eScience Pathfinding project: "Chemical Analytics Platform" BioAxis Research/RadboudUMC (Prof G Vriend)

 

 

 

Copyright © 2011-2016 All Rights Reserved